Why Lilly(Eli) & Co (LLY) Stock Is Rising
As of 2026-07-17, Lilly(Eli) & Co (LLY) has a next-year EPS growth estimate of 27.58%.
Why LLY Stock Is Rising
- +Sustained Upward Momentum: The estimate has risen consistently across 3 trading sessions since detection, now up a net +2.53 pp to 27.58%.
- ·Current-Year Growth: Projected at 46.35%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- EPS growth next year
- 27.58%
- EPS growth this year
- 46.35%
- EPS next quarter (est)
- $6.05
- Last price
- $1179.11
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 27.58% | 46.35% | $6.05 | $1179.11 |
| 2026-07-16 | 27.19% | 46.79% | $6.06 | $1169.17 |
| 2026-07-15 | 26.80% | 47.14% | $6.01 | $1156.63 |
| 2026-07-14 | 26.80% | 47.14% | $6.01 | $1152.54 |
| 2026-07-13 | 25.05% | 48.75% | $8.84 | $1181.87 |
Recent News
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Lilly(Eli) & Co (LLY) stock go up recently?▾
Lilly(Eli) & Co (LLY) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-07-13. The estimate has since risen consistently across 3 additional trading sessions, gaining a net +2.53 pp to 27.58%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Lilly(Eli) & Co's next-year EPS growth estimate?▾
As of 2026-07-17, Lilly(Eli) & Co (LLY) has a next-year EPS growth estimate of 27.58%, based on analyst consensus.
When was the latest EPS estimate revision for LLY?▾
The most recent revision occurred on 2026-07-17, when analysts adjusted the next-year EPS growth estimate from 27.19% to 27.58%.
What sector and industry does Lilly(Eli) & Co belong to?▾
Lilly(Eli) & Co operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LLY appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Lilly(Eli) & Co (LLY) appears here because it was detected by our daily top-EPS-revision-performer screen.